Prestige Consumer Healthcare Inc. (PBH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Key Insights
Critical company metrics and information
Share Price
$85.82Market Cap
$4.24 BillionTotal Outstanding Shares
49.41 Million SharesTotal Employees
570Dividend
No dividendIPO Date
February 10, 2005SIC Description
Pharmaceutical PreparationsHomepage
https://www.prestigebrands.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $-250.01 Million |
Net Cash Flow From Investing Activities, Continuing | $-23.66 Million |
Exchange Gains/Losses | $2.18 Million |
Net Cash Flow, Continuing | $-10.71 Million |
Net Cash Flow From Financing Activities | $-250.01 Million |
Net Cash Flow From Operating Activities, Continuing | $262.95 Million |
Net Cash Flow From Operating Activities | $262.95 Million |
Net Cash Flow From Investing Activities | $-23.66 Million |
Net Cash Flow | $-8.53 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Income/Loss Available To Common Stockholders, Basic | $205.95 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Benefits Costs and Expenses | $849.33 Million |
Diluted Average Shares | $150.43 Million |
Income Tax Expense/Benefit | $61.02 Million |
Revenues | $1.11 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Income Tax Expense/Benefit, Deferred | $17.71 Million |
Costs And Expenses | $851.69 Million |
Operating Income/Loss | $325.37 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Net Income/Loss | $205.95 Million |
Income/Loss From Continuing Operations Before Tax | $261.33 Million |
Gross Profit | $613.16 Million |
Net Income/Loss Attributable To Parent | $205.95 Million |
Cost Of Revenue | $497.50 Million |
Diluted Earnings Per Share | $4.11 |
Income/Loss From Continuing Operations After Tax | $205.95 Million |
Basic Earnings Per Share | $4.15 |
Operating Expenses | $287.79 Million |
Basic Average Shares | $149.30 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Non-current Assets | $544.72 Million |
Intangible Assets | $2.32 Billion |
Current Assets | $380.71 Million |
Assets | $3.32 Billion |
Current Liabilities | $106.91 Million |
Equity | $1.73 Billion |
Liabilities | $1.59 Billion |
Wages | $8.81 Million |
Inventory | $156.22 Million |
Accounts Payable | $31.17 Million |
Equity Attributable To Parent | $1.73 Billion |
Fixed Assets | $74.92 Million |
Other Non-current Liabilities | $426.63 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Liabilities And Equity | $3.32 Billion |
Other Current Liabilities | $51.21 Million |
Noncurrent Liabilities | $1.48 Billion |
Other Current Assets | $224.48 Million |
Interest Payable | $15.71 Million |
Long-term Debt | $1.05 Billion |
Noncurrent Assets | $2.94 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.